11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies
Folia Neuropathol. 2026;64(2):142-149. doi: 10.5114/fn.2026.163679. ABSTRACT INTRODUCTION: Glucocorticoid therapy is commonly used in inflammatory myopathies (IMs); however, patients’ responses are variable, and predictive biomarkers remain …